期刊文献+

人脑胶质瘤中耐药蛋白P-gp和MRP1的表达 被引量:3

Alteration of P-glycoprotein and multidrug resistance protein 1 in gliomas
下载PDF
导出
摘要 目的 探讨人脑胶质瘤中耐药蛋白P gp和MRP1表达情况。 方法  37例人脑胶质瘤标本 ,包括星形细胞瘤 2 5例 (纤维型 7例 ,原浆型 6例 ,间变型 12例 ) ,胶质母细胞瘤 12例 (多形性胶质母细胞瘤 4例 ) ;10例正常脑组织作为对照。P gp和MRP1的检测采用免疫组化ABC法。 结果P gp在肿瘤中阳性率为 2 4 3% ( 9/ 37) ,正常脑组织为 10 % ( 1/ 10 ) ,两者无统计学差异。MRP1在肿瘤中阳性率为 73% ( 2 7/ 37) ,正常脑组织无表达 ,两组间有明显差异。P gp和MRP1在标本血管内皮细胞中存在表达 ,其中P gp阳性率为 2 4 3% ( 9/ 37) ,MRP1为 35 1% ( 13/ 37)。 结论 人脑胶质瘤中 ,P gp和MRP1均有所表达 ,其中P gp较少 ,而MRP1明显增多 ,提示与耐药关系密切。在肿瘤血管内皮细胞中 ,两者存在异常 。 Objective To study the alteration of P glycoprotein (P gp) and multidrug resistance protein 1(MRP1)in gliomas.Methods Thirty seven gliomas were classified by WHO standard (1990) as astrocytomas (25 cases,including fibrillary,7 cases;protoplasmic,6 cases;anaplastic,12 cases),glioblastomas (12 cases,including GBM,4 cases).Ten normal brain tissues were taken as control.The expression of P gp and MRP1 were detected by immunohistochemical method.Results In gliomas the positive rate of P gp was 24 3%(9/37),but was 10%(1/10) in normal brain tissue.There was no statistics difference between them.The ratio of positive cells was less than 30% in positive specimens.The positive rate of MRP1 was 73%(27/37),whereas there was none in normal brain tissue.There was significance between them.P gp and MRP1 were seen in tumor blood vessel endothelium,the former being 24 3%(9/37),the latter being 35 1%(13/37).Conclusion Both P gp and MRP1 were expressed in gliomas,in which MRP1 was more than P gp.In tumor blood vessel endothelium the two proteins were abnormal,which indicated that blood brain barrier (BBB) might contribute to mutidrug resistance.
出处 《江苏医药》 CAS CSCD 北大核心 2003年第5期341-343,共3页 Jiangsu Medical Journal
基金 江苏省卫生厅重点科研项目资助 (编号 :H2 0 0 119)
关键词 脑胶质瘤 耐药现象 产生机制 P-糖蛋白 多药耐受蛋白1 血脑屏障 Gliomas P glycoprotein(P gp) Multidrug resistance protein 1(MRP1) Blood brain barrier
  • 相关文献

参考文献3

  • 1Dominique S. Tews,Anja Nissen,Claudia Külgen,Andreas K.A. Gaumann. Drug Resistance-associated Factors in Primary and Secondary Glioblastomas and their Precursor Tumors[J] 2000,Journal of Neuro - Oncology(3):227~237
  • 2L. Rieger,J. Rieger,S. Winter,J. Streffer,P. Esser,J. Dichgans,R. Meyermann,M. Weller. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo[J] 2000,Acta Neuropathologica(5):555~562
  • 3TatsuyaT. Abe,TeruakiT. Mori,YukihiroY. Wakabayashi,MasayukiM. Nakagawa,SusanS.P.C. Cole,KohjiK. Koike,MichihikoM. Kuwano,ShigeakiS. Hori. Expression of multidrug resistance protein gene in patients with glioma chemotherapy[J] 1998,Journal of Neuro - Oncology(1):11~18

同被引文献24

  • 1王建奇,卢洪流,韩燕华,柯以铨,徐如祥.脑胶质瘤中端粒酶活性及P-gp糖蛋白表达的相关性[J].军事医学科学院院刊,2004,28(6):527-529. 被引量:1
  • 2唐淑红,聂慧玲.耐药基因与凋亡相关基因在肺癌中的表达及其意义[J].中国肿瘤临床与康复,2005,12(1):28-29. 被引量:2
  • 3王存祖.人脑胶质瘤化疗耐药研究进展[J].江苏大学学报(医学版),2005,15(3):271-273. 被引量:5
  • 4段钊,曲群,赵玲,陈青娟,王桂贤,马玉琴,杜稳侠.P-gp和Topo-Ⅱ在子宫内膜癌组织中的表达及意义[J].中华肿瘤防治杂志,2006,13(24):1873-1875. 被引量:1
  • 5Valera ET, Lucio Eterovic AKB, Neder L, et al. Quantitative PCR analysis of the expression profile of gene related to multiple drug resistance in tumors of the central nervous system[J]. J Neurooncol,2007,85(1) : 1-10.
  • 6Kolfschoten GM , Hulscher TM, Pinedo HM, et al. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts[J].Br J Cancer,2000,83(7):921-927.
  • 7Moran E, Cleary I, Larkin AM, et al. Co-expression of MDRassociated markers, including P 170, MRP and LRP and eytoskeletal proteins,in three resistant variants of the human ovarian carcinoma cell line, OAW 42 [J]. Eur J Cancer, 1997, 33(4):652-660.
  • 8Laurencot CM , Scheffer GL , Scheper RJ, et al. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines[J]. Int J Cancer, 1997,72(6) : 1021-1026.
  • 9Katsaros H, Massobrio M, Arts HJ, et. al. Expression of drug resistance-associated markers Pgp. Mrpl. Mrp2 and Lrp in ovarian cancer: clinical implications [J]. Minerra Ginecol, 2000,4(70) :463-470.
  • 10Anda T, Shabani HK, Tsunoda K, et al. Relationship between expression of O-6-methylguanine DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistoehemical analysis[J]. Neurol Res,2003,25(3): 241-248.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部